CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-09 | SULLIVAN LOUIS W Director | Option exercise | +650 | 2,983 | ||
| 2026-07-09 | SULLIVAN LOUIS W Director | Option exercise · Restricted Stock Unit | −650 | 0 | ||
| 2026-07-09 | KURZWEIL RAY Director | Option exercise | +650 | 13,320 | ||
| 2026-07-09 | KURZWEIL RAY Director | Option exercise · Restricted Stock Units | −650 | 0 | ||
| 2026-07-09 | MALCOLM JAN Director | Option exercise 10b5-1 | +650 | 775 | ||
| 2026-07-09 | MALCOLM JAN Director | Option exercise · Restricted Stock Unit 10b5-1 | −650 | 0 | ||
| 2026-07-09 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $135.42 | $1.3M | 50,013 |
| 2026-07-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −440 | $548.16 | $241K | 49,573 |
| 2026-07-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,536 | $549.01 | $843K | 48,037 |
| 2026-07-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,452 | $550.12 | $799K | 46,585 |
| 2026-07-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,863 | $551.03 | $1.6M | 43,722 |
| 2026-07-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,648 | $552.38 | $910K | 42,074 |
| 2026-07-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −801 | $553.29 | $443K | 41,273 |
| 2026-07-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −640 | $554.23 | $355K | 40,633 |
| 2026-07-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $555.76 | $67K | 40,513 |
| 2026-07-09 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 30,218 | ||
| 2026-07-08 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $135.42 | $1.3M | 50,013 |
| 2026-07-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −637 | $548.62 | $349K | 49,376 |
| 2026-07-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −923 | $549.52 | $507K | 48,453 |
| 2026-07-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −785 | $550.45 | $432K | 47,668 |
Page 70 of 120 · 2,391 trades